Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients

NCT06666998 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-11-04

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of Eravacycline in the treatment of patients with bacterial infection and to assess the pharmacokinetics of Eravacycline and to establish a population pharmacokinetic model of Eravacycline.

Conditions

  • Eravacycline
  • Pharmacokinetics
  • Bacteria Infection
  • Bacterial Resistance to Antimicrobial
  • Empirical Antimicrobial Therapy

Sponsors & Collaborators

  • Sichuan Provincial People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2026-11-01
Completion
2026-11-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06666998 on ClinicalTrials.gov